Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Amyloid Formation—Taking Things One Monomer at a Time
23 September 2004. Amyloids, whether of the amyloid-β of Alzheimer disease, or of other peptides such as transthyretin, are composed of long polymeric fibrils that stick together like glue. But how are the fibers formed? Does a chain grow by the addition of single molecules at the end, or are medium-length pieces, or protofibrils, of up to 10, 20, or more monomers shunted together like a freight train? The answer is important because evidence suggests that protofibrils are the most toxic form of Aβ (see ARF related news story), and understanding their formation and consumption is tantamount to understanding the dynamics of Aβ toxicity.

In the October PLoS Biology, already available online, Jonathan Weissman and colleagues from the University of California at San Francisco report that amyloid derived from the yeast prion, Sup35, forms by the simple addition of monomers to the end of a growing chain, even in the presence of oligomers. The finding suggests that other amyloids may grow in a similar fashion.

First author Sean Collins and colleagues used the NM domain of Sup35 to measure amyloid formation in an analytical ultracentrifuge, which revealed that NM existed predominantly as monomers during the process. Using a thioflavin binding assay, they were also able to show that the kinetics of amyloid formation fit a monomeric addition model perfectly. Seeding the reaction with preformed fibers also resulted in chain growth by monomer addition. But perhaps the strongest evidence for monomer addition came from direct visible measurement of fiber growth. Using a total internal reflection fluorescence microscope, Collins and colleagues were able to measure the addition of fluorescently labeled NM to an NM fiber bound to a glass slide. The fluorescence accumulated specifically at the fiber ends, and those spots were stable—most of them could be seen 15 seconds later, whereas less than 20 percent of spots survived as long if fiber ends were absent—suggesting that the monomers had bound tightly.

“Many kinetic features seen for NM polymerization are shared by other amyloidogenic proteins, suggesting that monomer addition may represent a mechanism of amyloid growth common to other fibers,” state the authors. They also speculate that if this is true, then agents designed to promote direct fiber formation could help prevent the formation of the shorter, potentially toxic oligomers.—Tom Fagan.

Reference:
Collins SR, Douglass A, Vale RD, Weissman JS. Mechanism of prion propagation: Amyloid growth occurs by monomer addition. PLoS Biology. 2004 October 12;2:e321-. Abstract

 
Comments on News and Primary Papers
  Comment by:  luee rene
Submitted 26 September 2004  |  Permalink Posted 27 September 2004
  I recommend the Primary Papers
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad